"Leishmaniasis, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Descriptor ID |
D016773
|
| MeSH Number(s) |
C03.752.300.500.400 C03.858.560.400 C17.800.838.775.560.400
|
| Concept/Terms |
Oriental Sore- Oriental Sore
- Sore, Oriental
- Leishmaniasis, Old World
- Old World Leishmaniasis
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Cutaneous".
This graph shows the total number of publications written about "Leishmaniasis, Cutaneous" by people in this website by year, and whether "Leishmaniasis, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 2 | 4 |
| 2017 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis, Cutaneous" by people in Profiles.
-
Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection. Int Immunopharmacol. 2024 Jun 15; 134:112100.
-
Toll-like receptor 2 selectively modulates Ras isoforms expression in Leishmania major infection. Cytokine. 2023 09; 169:156301.
-
Genomic analysis of two phlebotomine sand fly vectors of Leishmania from the New and Old World. PLoS Negl Trop Dis. 2023 04; 17(4):e0010862.
-
How I Approach Leishmaniasis: Diagnosis and Treatment in the United States. J Pediatric Infect Dis Soc. 2022 Dec 05; 11(11):525-532.
-
TLR2 dimer-specific ligands selectively activate protein kinase C isoforms in Leishmania infection. Immunology. 2021 10; 164(2):318-331.
-
Interdependencies between Toll-like receptors in Leishmania infection. Immunology. 2021 09; 164(1):173-189.
-
Conundrums in leishmaniasis. Cytokine. 2021 09; 145:155304.
-
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis. Protein Expr Purif. 2021 01; 177:105750.
-
Development and Characterization of an Avirulent Leishmania major Strain. J Immunol. 2020 05 15; 204(10):2734-2753.
-
Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates. PLoS Negl Trop Dis. 2019 02; 13(2):e0007092.